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Abstract 1 
A potent natural antimicrobial peptide named temporin-PE was identified and encoded from 
the skin secretions of Pelophylax kl. esculentus via “shotgun” cloning and LC-MS/MS 
fragmentation analysis. Target-modifications were carried out to further enhance the antimicrobial 
and anti-proliferative bioactivities, whilst decreasing the hemolytic effect. A range of bioassays 
demonstrated that replacing a proline with a tyrosine residue resulted in a loss of the bioactivity 
against Gram-negative bacteria, but dramatically improved the hemolytic and anti-proliferative 
activity, indicating the FLP- motif influences the hemolytic activity of temporins. Moreover, the 
coupling of TAT to the peptide dramatically improved its antimicrobial activity, indicating 
coupling TAT to these peptides could be considered as a potential tool to improve their 
antimicrobial activity. Overall, we have shown that targeted modifications of this natural 
antimicrobial peptide can adjust its bioactivities to help its development as an antibiotic or 
anti-proliferative agent. 
                                                              
1Abbreviations：AMP, antimicrobial peptide; GM, the geometric mean; TI, the therapeutic index 
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Introduction 
Anurans are a group of morphologically specialized amphibians widely distributed around the 
world. P. kl. esculentus is a common species of frog in Europe, where  it is also known as the edible 
frog. Although P. kl. esculentus, previously known as “Rana esculenta”, is a hybrid of the pool frog 
(Rana lessonae) and the marsh frog (Rana ridibunda), it possesses superior skin peptide immune 
defenses. Compared to the parental species, this hybrid species not only produces the most diverse 
peptides, but the antibiotic activity and stability of its antimicrobial peptides (AMPs) are also 
superior [1]. Therefore, the innate immune defense system of P. kl. esculentus is worthy of  
detailed research.  
To date, more than thirty different AMPs have been discovered from the edible frog [2-9], 
most of which are brevinins [4, 6-8], esculentins [4] and temporins [5, 6, 9, 10]. Besides, there are 
also protease inhibitors [11] and bradykinins [12] in the skin secretions of P. kl. esculentus. 
According to the literature, temporins are a group of AMPs with potential to be developed as novel 
antibiotic agents due to their ability to kill microorganisms, including antibiotic-resistance bacteria. 
Temporins are short, C-terminally α-amidated, highly hydrophobic and weakly charged or 
non-charged [13]. Their secondary structures are usually linear and α-helical, which is one of the 
critical elements contributing to their cytotoxic effects upon microbial and cancer cells, due to their 
ability to destabilize membranes. Although, it is common for some AMPs to exhibit activity against 
cancer cells, and temporins have been shown to permeabilize several cell types, there are few 
reports about the impact of temporins on cancer cells, indeed, only the antimicrobial temporin-1CEa 
and temporin-La have been shown to exert significant activity against cancer cells [14-17]. The 
mechanism by which temporins impact upon cancer cells has been shown to relate to intracellular 
mechanisms involving mitochondria, including Ca2+ leakage, the collapse of mitochondrial 
membrane potential and over-generation of reactive oxygen species and membrane-denaturation 
due to the electrostatic interaction between the cationic peptides and anionic cell membrane [14, 
17].   
 
Materials and Methods 
Specimen Biodata and Harvesting of Skin Secretion 
The frogs were obtained, fed and skin secretions were harvested from the edible frog as 
described previously [9]. These procedures were subject to ethical approval and carried out under 
appropriate UK animal research personal and project licenses.  
 
Molecular Cloning of Temporin-PE Precursor-Encoding cDNA 
The “shotgun” cloning was carried out as previously described [9]. A degenerated primer 
(5’-GAWYYAYYHRAGCCYAAADATGTTCA-3’) (W = A or T; Y = C or T; H = A or C or T; R 
= A or G; D = A or G or T) was subjected to 3’-RACE reaction, from which the products were 
cloned and subsequently sequenced.  
 
Identification of Temporin-PE in the skin secretion 
The skin secretion was fractionated by RP-HPLC and all fractions were subjected to 
MALDI-TOF mass spectrometer. Then the fraction containing the same molecular weight of the 
putative mature peptide was analyzed by MS/MS fragmentation sequencing. The experimental 
procedures for RP-HPLC, MALDI-TOF and LC-MS/MS have been described previously [18].  
 
Design and Chemical Synthesis of Peptides 
Here, the natural-occurring temporin-PE was employed as a template for the targeted design. 
The temporins present in P. kl. esculentus are structurally similar to peptides discovered in wasp 
venom, which display a conserved N-terminal FLP motif which caused hemolysis [19]. Therefore, 
to determine if this motif was causing a similar impact in temporin-PE, we modified the FLP motif 
to produce temporin-PEa and examined its hemolytic activity. Particularly, substituting Pro3 by 
Tyr3, designed by the genetic algorithm (GA) mutation in HeliQuest tool, was used to change the 
backbone of temporin-PE but remained the similar physicochemical parameters, namely 
temporin-PEa. Meanwhile, another analog was designed by coupling a TAT (-GRKKRRQRRR-) at 
the C-terminus of temporin-PE, namely temporin-PEb, in order to enhance the cell penetrating 
activity as well as investigate the potential intracellular targets of temporin-PE [20]. All peptides 
were chemically-synthesized by solid phase Fmoc chemistry [18].  
 
Predicted Physicochemical Parameters, and Secondary Structures of Peptides 
The secondary structure predictions and models were processed using the I-TASSER server 
[21-24]. The helical wheels and the physiochemical parameters of peptides were predicted using the 
HeliQuest tool [25, 26]. The secondary structures of all peptides were examined by circular 
dichroism (CD) and analyzed by the K2D3 web server as described before [18].  
 
Antimicrobial Assay 
The minimal inhibitory concentrations (MICs) of peptides were evaluated by the standard 
microdilution assay described previously [18]. Six different microorganism strains, Candida 
albicans (NCPF 1467), Staphylococcus aureus (NCTC 10788), Escherichia coli (NCTC 10418), 
Methicillin-resistant S. aureus (MRSA) (NCTC 12493), Enterococcus faecalis (NCTC12697) and 
Pseudomonas aeruginosa (ATCC 27853), were utilized in this assay. The geometric mean (GM) of 
MICs for each peptide to inhibit the growth of C. albicans, S. aureus, E. coli, MRSA, E. faecalis 
and P. aeruginosa, was calculated to estimate the overall antimicrobial activity of peptides. The 
therapeutic index (TI) of the peptide was shown as the ratio of HC50 for erythrocytes to the GM. 
The HC50 here is the concentration of a peptide inducing 50% erythrocyte hemolysis. 
 
Time-killing assay 
The time killing assay was performed following the Corinne’s protocol with modifications 
[27]. Briefly, S. aureus (NCTC 10788) and MRSA (NCTC 12493) were employed in this assay.  
4μM, 2μM and 1μM of each peptide were applied for S. aureus and 8μM, 4μM and 2μM were 
applied for MRSA. Appropriate time points were selected, as indicated, to observe the viable 
counts.  
 
Anti-proliferation assay 
The anti-proliferation assay was performed using MTT as in our previous studies [28, 29]. 
The non-small cell lung cancer cell line NCI-H157, human neuronal glioblastoma cell line 
U251MG, human prostate carcinoma cell line PC-3, melanoma cell line MDA-MB-435s and 
human microvessel endothelial cells HMEC-1 were utilized in this assay. The GMs for 
anti-proliferative activity were calculated. The TI value of each peptide was shown as the ratio of 
IC50 for HMEC-1 cells to the GM for four types of cancer cells. 
 
Hemolysis Assay 
The hemolysis bioactivity of the three peptides against defibrinated horse erythrocytes was 
determined following the same protocol as used previously [11, 28]. 1% TritonX-100 was 
employed as the positive control. 
 
Statistical Analysis 
All the bioactivity assays had five independent replicates. Data were subjected to statistical 
analysis using Prism (Version 5.0, U.S.A). The one-way ANOVA was used to calculate the 
significance of the sample set. Error bars in the charts indicate standard error of the mean.  
 
Results 
Molecular cloning of A Novel Precursor-encoding cDNA 
A nucleotide and translated amino acid sequence of an open-reading frame (ORF) encoding a 
potential antimicrobial peptide precursor were obtained via shotgun cloning (Figure 1). The petide 
consists of 62 amino acid residues,  divided into five definite domains including a highly conserved 
putative signal peptide region containing 23 amino acid residues, an acidic amino acid residue-rich 
“spacer” region, a typical -Lys-Arg- propeptide convertase processing site, a putative mature 
peptide region containing 13 amino acid residues, namely temporin-PE, and a C-terminal -Gly-Lys- 
propeptide which acts as an amide donor to C-terminal amindation of the mature peptide. The 
nucleotide sequence of temporin-PE has been deposited to GenBank under the accession code 
MF957260. 
 
Confirmation of the Primary Structure of Temporin-PE 
Abundant peaks were fractionated from the skin secretions of P. kl. esculentus by RP-HPLC 
(Figure 2A). MALDI-TOF confirmed the peak at 152 min was the fraction containing the predicted 
mature peptide (Figure 2C) and this this fraction was further analyzed via MS/MS fragmentation 
analysis (Figure 2B and Table 1). 
 
Secondary Structures and Physicochemical Properties of Temporin-PE, Temporin-PEa and 
Temporin-PEb 
Temporin-PE, Temporin-PEa and Temporin-PEb were all  predicted to be typical α-helical 
peptides (Figure 3A-C). The predicted helical wheel structures of these peptides demonstrated that 
all three contained a hydrophobic face, exhibiting that higher amphipathy of temporin-PEb than 
which of the other two (Figure 3D-F). Temporin-PE and temporin-PEa displayed similar 
physicochemical properties, while temporin-PEb exhibited a larger α-helical domain, higher net 
positive charges and hydrophilicity (Table 2). CD spectra of the peptides confirmed that the 
peptides were random coil but formed α-helical structures in the membrane-mimic environment 
(Figure 3G&H). Although the actual contents of α-helical domains of each peptide are lower than 
the predicted ones, it reveals that the temporin-PEb possesses the largest α-helical domain, whereas 
temporin-PEa contained the smallest.  
 
Antimicrobial assay 
Temporin-PE potently inhibited the growth of the pathogenic fungi (C. albicans), the 
Gram-positive bacteria S. aureus and MRSA, but showed lower efficacy against the Gram-negative 
bacteria such as E. faecalis and P. aeruginosa. Temporin-PEa exerted similar bioactivity except 
against the Gram-negative bacteria, E. coli and P. aeruginosa (Table 3). However, temporin-PEb 
showed the most potent antimicrobial bioactivity against all six microorganisms.  
 
Time-killing kinetics assay 
Temporin-PE and temporin-PEb showed concentration-dependent and time-dependent 
bactericidal activity against S. aureus and MRSA, however, temporin-PEa did not impact upon 
these two strains at all tested concentrations (Figure 4A-F). Temporin-PEb was the most potent 
AMP starting to kill S. aureus at concentrations from 1μM, while taking 30 minutes to kill MRSA at 
concentrations from 4μM. Temporin-PE displayed potent activity against S. aureus at 8μM, but was 
much less potent against MRSA.  
 
Cancer cell viability assay 
Since temporin-PE and the two designed analogs exerted cytotoxicity to pathogenic 
microorganisms and erythrocytes, the ability of them functioning to cancer cells were also studied. 
The result indicated that two designed peptides possessed more efficient anti-proliferative activity 
than temporin-PE (Figure 4G-K). However, unlike temporin-PEa without seriously cytotoxicity on 
normal human microvessel endothelial cells HMEC-1 at the 10μM, temporin-PEb showed 
nonspecific cytotoxicity towards all tested cell lines. Temporin-PEa displayed the relatively highest 
TI values than the other peptides (Table 4).  
 
Hemolysis assay 
Temporin-PE, temporin-PEa and temporin-PEb exhibited different degrees of hemolysis on 
horse erythrocytes with HC50 of 39.64μM, 531.7μM and 44.64μM, respectively. Temporin-PEa 
and temporin-PEb possessed lower hemolytic activity than temporin-PE, especially temporin-PEa, 
with 13-fold less hemolytic activity.  
 
Discussion 
To date, except temporin-PE, only five temporins have been isolated from P. kl. esculentus [5, 
6, 9, 10]. According to the literature, temporin-PE possesses potent antimicrobial activity which is 
25-fold, 4-fold and 2.5-fold stronger than the best inhibitory effects of other reported temporins in 
P. kl. esculentus against C. albicans, S. aureus and E. coli respectively (Table 5). It is noteworthy 
that most temporin members have the common motif FLP- at their N-termini and a leucine at the 
second position near their C-termini, as well approximately 70% hydrophobic residues, which 
make them highly hydrophobic [30]. Compared to temporin-1Ec and temporin-1Ee, temporin-PE 
exhibited a more potent antimicrobial activity, something which could be explained by the 
position of the positive charge in its sequence. Temporin-PE, containing a lysine residue at 
position 7 (Lys7), possesses a more potent antimicrobial effect, especially against the growth of 
fungi, as Lys7 is located on the hydrophilic face of the helix domain, while a lysine residue at 
position 11 might not be on the hydrophilic face unless the helical domain extended to the 
C-terminus [31]. We therefore presumed that the lysine located on the hydrophobic region or 
random domain could not play roles as well as that on the hydrophilic region of temporins 
especially in the field of electrostatic interactions and bindings with negatively charged residues in 
the cell membranes. 
Temporin-PEa retained its antimicrobial activity except which was against Gram-negative 
bacterium. Both peptides share the similar secondary structure and physicochemical properties 
relating to antimicrobial activity, which suggested the significance of Pro on membrane 
interaction between peptides and Gram-negative bacterium membrane. Usually, AMPs firstly bind 
lipopolysaccharide (LPS) micelles when they interact with Gram-negative bacterium. Such 
binding might lead some AMPs to translocate through the outer membrane of Gram-negative 
bacterium, as the magnesium and calcium ions that hold together LPS would replace metal ions, 
breaking the outer membrane, and resulting in facilitating entry of additional AMPs from the 
exterior [32]. Previous studies have shown that proline plays an essential role in outer membrane 
disruption and bacterial cell lysis activity, as the more proline residues present, the stronger the 
binding between AMPs and LPS [33]. Therefore, removing the proline might decrease the LPS 
binding affinity, meaning temporin-PEa could not overcome the LPS hurdle and the integrity of 
these bacterial cells would not be disrupted, resulting in a loss of activity against Gram-negative 
bacterium. Moreover, compared to tyrosine, proline, which usually forms a slight hinge structure, 
is more possible to make peptides more easily to fasten on the zwitterionic membrane. That is 
confirmed what we had anticipated, the temporin-PEa showed a vastly reduced hemolytic activity 
indicating this FLP motif is again important in these peptides. However, it increased the 
anti-proliferative activity against cancer cells. As it is reported, the plasma membrane surface of 
cancer cells contains abundant phosphatidylserines, glycoproteins, gangliosides and some other 
anionic molecules, some of which are often over-expressed in cancer cell lines [34]. That is 
presumably the reason why the substitution of proline with tyrosine leads to a decreased toxicity 
towards normal cells, but shows increased anti-proliferative activity toward cancer cells. We 
would therefore hypothesize this anti-proliferative activity results from the phenolic hydroxyl 
moieties binding to target molecules, such as sialic acids of the O-glycoproteins, N-glycoproteins 
and gangliosides, which are overexpressed on cancer cells.  
TAT is an arginine-rich decapeptide derived from HIV-1, an ideal cell-penetration segment to 
transit drugs through cell membranes via membrane translocation and endocytosis, with no 
hemolytic effects, mild antibiotic activity and inhibits the growth of fungi with MICs ranging from 
3μM to 24μM [35]. We hypothesized that the electrostatic forces between temporin-PEb and 
anionic cell membranes would become much stronger when eight positive charges were 
introduced as part of TAT. Compared to temporin-PE, temporin-PEb demonstrated an 8-fold and 
64-fold stronger antimicrobial effect against E. coli and P. aeruginosa respectively, 4-fold 
stronger against C. albicans and E. faecalis, and two-fold against S. aureus and MRSA. In 
addition, temporin-PEb also acted more rapidly against these microporganisms. Although the 
antimicrobial mechanism of temporin-PEb was not verified experimentally, it is presumed that the 
addition of TAT improved the electrostatic interaction, as well as helping the peptide to penetrate 
into the cytoplasm to interfere the biological processes such as DNA replication and protein 
synthesis, leading to its markedly improved antimicrobial activity [36]. Meanwhile, the 
anti-proliferative activity of temporin-PEb was also increased against all the cell lines examined. 
So we hypothesize that temporin-PEb might not only disrupt the plasma membrane through the 
permeabilization, but also involve the intracellular targets, such as mitochondrial membrane, after 
the penetrating the cell membrane by TAT.  
In summary,  this study has identified a novel temporin which shows potent antimicrobial 
activity. We then designed target-modifications to enhance the antimicrobial and anti-proliferative 
bioactivities of this peptide, whilst decreasing its hemolytic effect. The substitutions made 
demonstrated that the FLP motif, as previously shown for other similar peptides, is associated with 
the hemolytic activity of temporin-PE. In addition, modifying the FLP motif also decreased the 
potency of this peptide against Gram-negative bacteria, while enhancing its anti-proliferative 
activity. Furthermore, this work shows that introducing a TAT peptide at the C-terminus of 
temporin dramatically increased the antimicrobial activity of temporin-PE. Therefore, this study 
has opened up new perspectives on how modifying natural AMPs can alter their bioactivities. 
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Legends to Figures and Tables 
Figure 1. Nucleotide and translated ORF amino acid sequences of the precursor cDNA encoding 
the peptide temporin-PE, from the skin secretions of P. kl. esculentus. The putative signal peptide 
sequence is single-underlined, the mature peptide sequence is double-underlined, and an asterisk 
indicates the stop codon. 
Figure 2. (A) RP-HPLC chromatogram of skin secretion of RP-HPLC P. kl. esculentus at a 
wavelength of 214nm. The peak with an arrow is the peak of temporin-PE. (B) The annotated 
MS/MS spectrum of the RP-HPLC fraction of temporin-PE. (C) MALDI-TOF mass spectrum of 
the RP-HPLC fraction containing temporin-PE. 
Figure 3. Predicted secondary structure models of (A) temporin-PE (B) temporin-PEa, (C) 
temporin-PEb and helical wheel projections of (D) temporin-PE, (E) temporin-PEa, (F) 
temporin-PEb; CD spectra of temporin-PE and its analogs (50μM) (G) in 10 mM ammonium 
acetate water solution and (H) in 50% TFE/10 mM ammonium acetate water solution. The arrows 
indicate the hydrophobic regions. 
Figure 4. The time-killing kinetics of three peptides at different concentrations of (A) 4μM, (B) 
2μM, (C) 1μM against S. aureus and (D) 8μM, (E) 4μM, (F) 2μM against MRSA; The cell 
viabilities of (G) NCI-H157 (H) U251MG (I) PC-3 (J) MDA-MB-435s (K) HMEC-1 and the 
hemolytic effects (L) after treatment of temporin-PE and its analogs 
Table 1. Expected b- and y-ions arising from collision induced of the doubly-charged precursor 
ion. Actual fragment ions observed in MS/MS fragmentation are marked with the 
single-underlined bold typeface. 
Table 2. Primary structures, predicted secondary structures and physicochemical properties of 
temporin-PE, temporin-PEa and temporin-PEb 
Table 3. MICs, GMs and TI values of Temporin-PE, Temporin-PEa and Temporin-PEb against six 
microorganisms 
Table 4. Impact of temporin-PE, temporin-PEa and temporin-PEb on cancer cell viability 
Table 5. A comparison of the primary structures and MICs of temporins discovered in P. kl. 
esculentus 
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Table 1.  
#1 b(1+) b(2+) Seq. y(1+) y(2+) #2 
1 148.0757 74.54149 F     13 
2 261.15977 131.08352 L 1235.84503 618.42615 12 
3 358.21254 179.60991 P 1122.76096 561.88412 11 
4 471.29661 236.15194 I 1025.70819 513.35773 10 
5 570.36503 285.68615 V 912.62412 456.8157 9 
6 641.40215 321.20471 A 813.5557 407.28149 8 
7 769.49712 385.2522 K 742.51858 371.76293 7 
8 882.58119 441.79423 L 614.42361 307.71544 6 
9 995.66526 498.33627 L 501.33954 251.17341 5 
10 1082.69729 541.85228 S 388.25547 194.63137 4 
11 1139.71876 570.36302 G 301.22344 151.11536 3 
12 1252.80283 626.90505 L 244.20197 122.60462 2 
13     L-Amidated 131.1179 66.06259 1 
 
Table 2.  
 Peptides 
Temporin-PE Temporin-PEa Temporin-PEb 
Sequence FLPIVAKLLSGLLa FLYIVAKLLSGLLa FLPIVAKLLSGLLGRKKRRQRRRa 
Structure Prediction1 CCHHHHHHHHCCC CHHHHHHHHHCCC CCHHHHHHHHHHHHHHHHHHHCC 
Confident Score 9127999975329 9613998872439 91389999998861068877329 
Actual α-helix (%) 47.65 40.37 55.43 
Nonpolar residues (%) 76.92 76.92 43.48 
Hydrophobicity (H) 1.024 1.042 0.220 
Hydrophobic moment (μH) 0.570 0.552 0.304 
Net charge +2 +2 +10 
1 C, Coil; H, Helix 
 
Table 3. 
Microorganism 
 
Peptide 
MIC (μM) 
GM (μM) TI C. 
albicans 
S. 
aureus E. coli MRSA 
E. 
faecalis 
P. 
aeruginosa 
temporin-PE 4 2 16 4 8 128 8.98 4.41 
temporin-PEa 2 1 >512 2 2 >512 10.08 52.23 
temporin-PEb 1 1 2 2 2 2 1.59 28.08 
 
Table 4. 
 Cell line 
Peptide 
temporin-PE temporin-PEa temporin-PEb 
IC50 (μM) 
NCI-H157 34.56 3.398 3.464 
U251MG 25.13 3.520 3.087 
PC-3 38.56 27.62 3.051 
MDA-MB-435s 33.23 9.864 3.483 
HMEC-1 58.62 40.30 9.976 
GM (μM)  32.48 7.555 3.265 
TI  1.805 5.334 3.055 
* NC, not calculated 
 
Table 5. 
Peptide sequence Hydrophobicity Hydrophobic Net MIC (μM) 
(H) moment (μH) charge C. 
albicans 
S. 
aureus 
E. 
coli 
temporin-PE FLPIVAKLLSGLLa 1.024 0.570 +2 4 2 16 
temporin-1Ec FLPVIAGLLSKLFa 1.031 0.598 +2 >160 10 40 
temporin-1Ee FLPVIAGVLSKLFa 0.994 0.586 +2 >100 8 >100 
temporin-1Re FLPGLLA---GLLa 1.132 0.507 +1 >160 60 >160 
A1 FLPAIAGILSQLFa 1.028 0.587 +1 ND1 >200 >50 
B9 FLPLIAGLLGKLFa 1.071 0.585 +2 ND ND ND 
1 ND, not determined 
